Dallas--The nation's leading biomedical researchers will present breakthrough therapies and technologies in liver disease November 5 through November 9 at the 50th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), the leading medical organization dedicated to the study of the liver and its diseases.
AASLD encourages the media to attend the more than 1000 presentations covering liver-related diseases featuring previously unpublished findings on such diverse topics as:
- Using alcohol to repair a damaged liver
- Prediction that Hepatitis C-related carcinoma will impact U.S. soon
- Prevalence and risk factors for hepatitis C infection in U.S. veterans
- Impact of race on response to anti-viral therapy in chronic Hepatitis C patients
A pressroom will be available for media representatives in the Wyndham Anatole Hotel, Dallas, Texas, on Saturday, Nov. 6 from 3 p.m. to 6 p.m., Sunday, Nov. 7, through Tuesday, Nov. 9, from 9 a.m. to 5 p.m. For copies of abstracts, abstract summary highlights and press releases, to arrange for pre-conference researcher interviews, or to pre-register for onsite press credentials, contact Kirk Monroe at: 202-789-8101, kmcpr@aol.com
AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver disease. Today, AASLD provides representation and education for nearly 2,400 liver researchers, physicians, and surgeons worldwide. Visit AASLD's website at: www.aasld.org